• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Addressing the Challenges of Bile Acid Diarrhea Diagnosis

Addressing the Challenges of Bile Acid Diarrhea Diagnosis

by Michael Schubert, PhD | Jul 31, 2023 | Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.

This content is for Paid Members only.
Login Register
How to Resolve Three Common Types of Preanalytical Interference

How to Resolve Three Common Types of Preanalytical Interference

by Michael A. Vera, BA, Joe M. El-Khoury, PhD, DABCC, FACB | Jan 26, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Experts share new strategies for dealing with hemolysis, icterus, and lipemia interference.

This content is for Paid Members only.
Login Register

Physicians Stress Urgent Need for COVID-19 Antibody Reference Testing Standard

by Glenn S. Demby | Jun 23, 2020 | Articles, Diagnostic Testing and Emerging Technologies

...

This content is for Paid Members only.
Login Register
Test Quality: New Study Casts Doubt on Whole Exome Sequencing’s Accuracy in Diagnosing Genetic Disorders

Test Quality: New Study Casts Doubt on Whole Exome Sequencing’s Accuracy in Diagnosing Genetic Disorders

by Glenn S. Demby | Jan 24, 2020 | Diagnostic Testing and Emerging Technologies

Depending on the reporting laboratory, patients who undergo whole exome sequencing may receive false negatives or incomplete test results. That is the finding of a new study published in Clinical Chemistry

This content is for Paid Members only.
Login Register
Standard Pathology Tests Outperform Molecular Subtyping in Bladder Cancer Tumor Classification

Standard Pathology Tests Outperform Molecular Subtyping in Bladder Cancer Tumor Classification

by Glenn S. Demby | Jan 19, 2020 | Articles, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

...

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com